Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma (Q59791012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

1 reference

diffuse large B-cell lymphoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Çiğdem Atayar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Léon C van Kempen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Arjan Diepstra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Anke van den Berg

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

author name string

Annika Seitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Martijn Terpstra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Gustaaf W van Imhoff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Philip M Kluin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Tom van Meerten

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

Klaas Kok

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

language of work or name

English

0 references

publication date

20 November 2018

0 references

published in

Cancers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

5 May 2020

page(s)

459

0 references

copyright license

start time

20 November 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

12 December 2020

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue

1 reference

12 December 2020

Fast and accurate long-read alignment with Burrows-Wheeler transform

1 reference

12 December 2020

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

1 reference

12 December 2020

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

1 reference

12 December 2020

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

1 reference

12 December 2020

The variant call format and VCFtools

1 reference

12 December 2020

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

1 reference

12 December 2020

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

1 reference

12 December 2020

Analysis of the coding genome of diffuse large B-cell lymphoma

1 reference

12 December 2020

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

1 reference

12 December 2020

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

12 December 2020

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.

1 reference

12 December 2020

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3

1 reference

12 December 2020

From drug discovery to biomarker-driven clinical trials in lymphoma

1 reference

12 December 2020

Recurrent targets of aberrant somatic hypermutation in lymphoma

1 reference

12 December 2020

Genetic heterogeneity of diffuse large B-cell lymphoma

1 reference

12 December 2020

SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients

1 reference

12 December 2020

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

1 reference

12 December 2020

The implications of clonal genome evolution for cancer medicine

1 reference

12 December 2020

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

1 reference

12 December 2020

The Genome of the Netherlands: design, and project goals

1 reference

12 December 2020

dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations

1 reference

12 December 2020

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

1 reference

12 December 2020

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

1 reference

12 December 2020

Ibrutinib resistance in chronic lymphocytic leukemia

1 reference

12 December 2020

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

1 reference

12 December 2020

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.

1 reference

12 December 2020

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

1 reference

12 December 2020

Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization

1 reference

12 December 2020

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation

1 reference

12 December 2020

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

1 reference

12 December 2020

Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma.

1 reference

12 December 2020

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

1 reference

12 December 2020

Mutations driving CLL and their evolution in progression and relapse

1 reference

12 December 2020

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

1 reference

12 December 2020

A comprehensive survey of the mutagenic impact of common cancer cytotoxics

1 reference

12 December 2020

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

1 reference

12 December 2020

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma

1 reference

12 December 2020

Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.

1 reference

12 December 2020

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

1 reference

12 December 2020

Diffuse large B-cell lymphoma genotyping on the liquid biopsy

1 reference

12 December 2020

Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma

1 reference

12 December 2020

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?

1 reference

12 December 2020

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

1 reference

12 December 2020

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

1 reference

12 December 2020

Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma.

1 reference

12 December 2020

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

1 reference

12 December 2020

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

1 reference

12 December 2020

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.3390/CANCERS10110459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30463380%20AND%20SRC:MED&resulttype=core&format=json

5 May 2020

1 reference